Disorders of Thrombosis and Hemostasis in Pregnancy 2015
DOI: 10.1007/978-3-319-15120-5_2
|View full text |Cite
|
Sign up to set email alerts
|

Anticoagulants and Antiplatelet Agents in Pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 133 publications
0
3
0
Order By: Relevance
“…14 Figure 1 summarizes coagulation mechanisms and targets for actions of different anticoagulants. 15 Anticoagulation, in combination with corticosteroids, plasma exchange, and/or intravenous immunoglobulin (IVIG), is standard treatment for CAPS. 3,4,16 Non-criteria APS manifestations, which include livedo reticularis, thrombocytopenia, hemolytic anemia, cardiac valve disease, nephropathy, skin ulcers, and cognitive dysfunction, 1 are generally anticoagulant-refractory and require consideration of further therapeutic approaches.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…14 Figure 1 summarizes coagulation mechanisms and targets for actions of different anticoagulants. 15 Anticoagulation, in combination with corticosteroids, plasma exchange, and/or intravenous immunoglobulin (IVIG), is standard treatment for CAPS. 3,4,16 Non-criteria APS manifestations, which include livedo reticularis, thrombocytopenia, hemolytic anemia, cardiac valve disease, nephropathy, skin ulcers, and cognitive dysfunction, 1 are generally anticoagulant-refractory and require consideration of further therapeutic approaches.…”
Section: Introductionmentioning
confidence: 99%
“…Abbreviations: AT, antithrombin; LMWH, low molecular weight heparin; PC, protein C; PS, protein S; UFH, unfractionated heparin. (Adapted from Drebes et al 15 )…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation